Pharmaceutisch WeekbladOctober 1983, Volume 5, Issue 5, pp 261–268 | Cite asAbstracts of papersAuthorsAuthors and affiliationsA. Vercammen-GrandjeanG. RenouxN. P. E. VermeulenL. van BreeJ. de VriesJ. CommandeurB. B. LambertsF. A. M. RedegeldF. -J. van SchootenB. J. ScholteJ. de VriesG. S. P. GrootPierre M. LaduronM. A. BlankensteinArticle 12 Downloads This is a preview of subscription content, log in to check access.PreviewUnable to display preview. Download preview PDF.Unable to display preview. Download preview PDF.Copyright information© Bohn, Scheltema & Holkema 1983Authors and AffiliationsA. Vercammen-Grandjean1G. Renoux2N. P. E. Vermeulen3L. van Bree4J. de Vries4J. Commandeur4B. B. Lamberts4F. A. M. Redegeld4F. -J. van Schooten4B. J. Scholte5J. de Vries5G. S. P. Groot5Pierre M. Laduron6M. A. Blankenstein71.Laboratory of Oncology and Experimental SurgeryInstitut Jules BordetBrusselsBelgium2.Faculté de Médecine 2 bisLaboratoire d'ImmunologieTours CédexFrance3.Depts. of Pharmacology & Pharmaceutical Analysis, Subfac. of PharmacyUniversity of LeidenRA LeidenThe Netherlands4.Dept. of Pharmacochemistry, Subfaculty of ChemistrySection Molecular ToxicologyHV AmsterdamThe Netherlands5.Dept. of Biochemistry, Dept. of PharmacochemistryDe Vrye UniversiteitAmsterdamThe Netherlands6.Department of Biochemical PharmacologyJanssen Pharmaceutica Research LaboratoriesBeerseBelgium7.Department of BiochemistryRotterdamsch Radio-Therapeutisch InstituutAE RotterdamThe Netherlands